Phase 2 Breast Cancer Trial, Not Yet Recruiting NCT05806385 Sponsor: Texas Tech University Health Sciences Center Condition: Breast Cancer
Back to Breast Cancer

Phase 2 Breast Cancer Trial, Not Yet Recruiting

NCT05806385
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are female
  • People who have been diagnosed with Stage I or Stage II cancer
  • People between the ages of 18 and 90 years old
  • People diagnosed with invasive carcinoma that is triple negative (meaning the cancer tests negative for estrogen receptors, progesterone receptors, and HER2)
  • People whose cancer appears as a single, focused area when viewed on an ultrasound scan

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have more than one primary (original) cancer diagnosis
  • People diagnosed with inflammatory breast cancer
  • People with a history of an autoimmune disease (a condition where the immune system attacks the body's own cells)
  • People with a history of long-term use of medications that suppress the immune system
  • People who have previously received immunotherapy (a type of cancer treatment that uses the immune system)
  • People who have received a vaccine within the last 4 weeks
  • People who have previously received radiation therapy
  • People who have received an experimental treatment or therapy within the last year
  • People who are pregnant at the time of diagnosis or during treatment
  • People who are currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 1 July 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Texas Tech University Health Sciences Center
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 January 2027

Primary endpoints

Rate of Complete Pathological Response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov